ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV

02.06.25 12:11 Uhr

Werte in diesem Artikel

LOS ANGELES, June 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE: ELV) for violations of the federal securities laws.

DJS Law Group

Shareholders who purchased the Company's securities between April 18, 2024 and October 16, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 11, 2025.

CASE DETAILS:  The complaint alleges that the Company made false and misleading statements to the market concerning whether Elevance suffered from a significant rise in the acuity and utilization of its Medicaid members due to the program's redeterminations, because members removed from Medicaid were healthier than those who maintained eligibility. The shift in utilization experienced by the Company was not reflected in its rate negotiations with states or in its financial guidance to investors.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/elv-shareholders-have-the-right-to-lead-the-elevance-health-inc-securities-lawsuit---contact-the-djs-law-group-to-discuss-your-rights---elv-302470373.html

SOURCE DJS Law Group LLP

In eigener Sache

Übrigens: Elevance Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Elevance Health

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Elevance Health

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Elevance Health Inc Registered Shs

Wer­bung

Analysen zu Elevance Health Inc Registered Shs

DatumRatingAnalyst
01.11.2018Anthem OverweightBarclays Capital
13.07.2018Anthem OutperformBMO Capital Markets
08.03.2018Anthem OverweightBarclays Capital
06.12.2017Anthem BuyB. Riley FBR, Inc.
20.10.2017Anthem Market PerformBMO Capital Markets
DatumRatingAnalyst
01.11.2018Anthem OverweightBarclays Capital
13.07.2018Anthem OutperformBMO Capital Markets
08.03.2018Anthem OverweightBarclays Capital
06.12.2017Anthem BuyB. Riley FBR, Inc.
20.10.2017Anthem Market PerformBMO Capital Markets
DatumRatingAnalyst
05.04.2017Anthem HoldDeutsche Bank AG
29.10.2015Anthem Equal WeightBarclays Capital
29.10.2015Anthem Mkt PerformFBR Capital
30.04.2015Wellpoint Mkt PerformFBR Capital
20.03.2015Wellpoint Equal WeightBarclays Capital
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Elevance Health Inc Registered Shs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen